Pulmonary arterial hypertension, or PAH, is a rare and severe disease characterized by elevated blood pressure in the pulmonary arteries, which transport blood from the heart to the lungs. This can ...

A prespecified subgroup analysis showed that patients with intermediate and high-risk pulmonary arterial hypertension achieved significant improvements in walk distance and several secondary endpoints ...

Ah-Shi-Sle-Pah (gray salt in Navajo) is an official Bureau of Land Management wilderness area that has incredible land formations that will knock your socks off. It’s a little beyond the turnoff for ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human ...

Scientists have found that common foods can contain hidden contaminants formed during cooking or through environmental exposure. A new testing method called QuEChERS helps identify these chemicals ...

The fear of one day getting diagnosed with cancer is something we all share. In 2025 alone, there were over 2 million new cancer cases and over 600,000 deaths in the U.S. according to data from the ...

Well, great. Thank you, everybody, for being seated. Welcome. I'm Roger Jeffs, CEO of Liquidia, and welcome to our first ever R&D Day. We're really excited about what we're able to share with you ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an update to the U.S.

Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the arteries in your lungs. It happens when these arteries become narrow or blocked, making it harder for blood to flow ...

Sotatercept-csrk (Winrevair; Merck Sharp & Dohme) added on top of standard therapies improves outcomes in patients who are less than a year out from a diagnosis of pulmonary arterial hypertension (PAH ...

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--AliveGen USA Inc. (AliveGen), a clinical-stage biopharmaceutical company, today announced new preclinical data demonstrating that its investigational therapy ...